Incyte (INCY) — insider trading
Health Care · NASDAQ
Incyte (INCY) has 34 reported SEC Form 4 insider transactions in our data, including 2 open-market sales among the most recent 34 (latest 2026-07-16).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | Meury William | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 77,148 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Meury William | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 80,421 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Meury William | Director, Officer (Chief Executive Officer) | Grant / award / vesting | 26,807 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Hoffman Richard A. | Officer (EVP & General Counsel) | Grant / award / vesting (derivative) | 31,923 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Hoffman Richard A. | Officer (EVP & General Counsel) | Grant / award / vesting (derivative) | 18,487 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Hoffman Richard A. | Officer (EVP & General Counsel) | Grant / award / vesting | 7,395 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Gardner David H | Officer (EVP, Chief Strategy Officer) | Grant / award / vesting (derivative) | 31,923 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Gardner David H | Officer (EVP, Chief Strategy Officer) | Grant / award / vesting (derivative) | 18,487 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Gardner David H | Officer (EVP, Chief Strategy Officer) | Grant / award / vesting | 7,395 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Basi Ramitpal K | Officer (EVP, Human Resources) | Grant / award / vesting (derivative) | 21,548 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Basi Ramitpal K | Officer (EVP, Human Resources) | Grant / award / vesting (derivative) | 12,479 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Basi Ramitpal K | Officer (EVP, Human Resources) | Grant / award / vesting | 4,991 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Issa Mohamed Khairie | Officer (EVP, Head of U.S. Commercial) | Grant / award / vesting (derivative) | 33,918 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Issa Mohamed Khairie | Officer (EVP, Head of U.S. Commercial) | Grant / award / vesting (derivative) | 19,643 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Issa Mohamed Khairie | Officer (EVP, Head of U.S. Commercial) | Grant / award / vesting | 7,857 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Issa Mohamed Khairie | Officer (EVP, Head of U.S. Commercial) | Open-market sale | 1,093 | $115.01 | $125.7K | Form 4 |
| 2026-07-16 | CAGNONI PABLO J | Officer (President, Global Head of R&D) | Grant / award / vesting (derivative) | 57,861 | $0.00 | $0 | Form 4 |
| 2026-07-16 | CAGNONI PABLO J | Officer (President, Global Head of R&D) | Grant / award / vesting (derivative) | 33,508 | $0.00 | $0 | Form 4 |
| 2026-07-16 | CAGNONI PABLO J | Officer (President, Global Head of R&D) | Grant / award / vesting | 13,403 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Mayes Patrick A | Officer (EVP & Chief Scientific Officer) | Grant / award / vesting (derivative) | 25,538 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Mayes Patrick A | Officer (EVP & Chief Scientific Officer) | Grant / award / vesting (derivative) | 14,790 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Mayes Patrick A | Officer (EVP & Chief Scientific Officer) | Grant / award / vesting | 5,916 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Stein Steven H | Officer (CMO & Head of Late-Stage Dev.) | Grant / award / vesting (derivative) | 42,298 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Stein Steven H | Officer (CMO & Head of Late-Stage Dev.) | Grant / award / vesting (derivative) | 24,496 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Stein Steven H | Officer (CMO & Head of Late-Stage Dev.) | Grant / award / vesting | 9,798 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Stein Steven H | Officer (CMO & Head of Late-Stage Dev.) | Open-market sale | 1,877 | $114.73 | $215.3K | Form 4 |
| 2026-07-16 | Tray Thomas | Officer (Principal Accounting Officer) | Grant / award / vesting (derivative) | 4,079 | $0.00 | $0 | Form 4 |
| 2026-07-16 | Tray Thomas | Officer (Principal Accounting Officer) | Grant / award / vesting | 2,834 | $0.00 | $0 | Form 4 |
| 2026-07-15 | Tray Thomas | Officer (Principal Accounting Officer) | Shares withheld for taxes / exercise cost | 1,098 | $115.09 | $126.4K | Form 4 |
| 2026-07-15 | Mayes Patrick A | Officer (EVP & Chief Scientific Officer) | Shares withheld for taxes / exercise cost | 1,512 | $115.09 | $174.0K | Form 4 |
| 2026-07-15 | CAGNONI PABLO J | Officer (President, Global Head of R&D) | Shares withheld for taxes / exercise cost | 4,950 | $115.09 | $569.7K | Form 4 |
| 2026-07-14 | Tray Thomas | Officer (Principal Accounting Officer) | Shares withheld for taxes / exercise cost | 692 | $114.88 | $79.5K | Form 4 |
| 2026-07-14 | Mayes Patrick A | Officer (EVP & Chief Scientific Officer) | Shares withheld for taxes / exercise cost | 437 | $114.88 | $50.2K | Form 4 |
| 2026-07-14 | CAGNONI PABLO J | Officer (President, Global Head of R&D) | Shares withheld for taxes / exercise cost | 17,969 | $114.88 | $2.06M | Form 4 |
Ask the chat about INCY's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Incyte (INCY).
Last updated 2026-07-16 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.